surmount-1 tirzepatide non-diabetic obesity weight loss Demonstrates 94% Diabetes Reduction, 22% in SURMOUNT -1 Study Gastrointestinal tolerability and weight reduction
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7


























